Beyond excited to see our work in @JAMASurgery
We developed a risk score for recurrence and survival in LN–negative PanNETs, identifying patients at low, moderate, and high risk to guide risk-adapted postoperative surveillance and management. #PANDAjamanetwork.com/journals/jam…
DUPAN-2 was an effective surrogate biomarker for monitoring treatment response in patients with #PancreaticCancer who are carbohydrate antigen 19-9 nonexpressors, and normal levels were associated with improved outcomes.
ja.ma/4xissRB
ALT Research poster from JAMA Surgery: DUPAN-2 as a biomarker for 2,418 pancreatic cancer patients, particularly CA19-9 non-expressors. Survival curves & bar charts show DUPAN-2's correlation with overall survival for monitoring treatment.
Drain fluid amylase levels on postoperative days 1 and 3 accurately estimated the risk of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy. journals.lww.com/annalsofsur…
🚨 E-AHPBA Grand Rounds next week
Uncertainty and Decisions in the Surgical Management of PanNETs
📅 21 May 2026
🕕 18:00 CEST
💻 Free to attend
Don’t miss this engaging session in collaboration with SSO and NANETS - programme and registration details below 👇
🔗 eahpba.org/education-and-tra…#EAHPBAGrandRounds#PanNETs#HPBSurgery#SurgicalOncology
MARGINS SHOULD NOT AFFECT SURVIVAL IN SYSTEMIC CANCERS LIKE PDAC. Margins can be reflective of biology, similar to positive LNs. After neoadjuvant tx bad biology progress so for those getting tonsurgery margin loses its significance.
Honored to present our @JAMASurgery research today at the #SSO2026! Grateful to all the mentors and the scientific committee for this podium. Great HPB debates! @UCIrvineSurgery
Development and Prospective Validation of a Cell-free DNA–Based Model for the Early Detection of Pancreatic Cancer | Cancer Discovery | American Association for Cancer Research aacrjournals.org/cancerdisco…
Check out @AnnSurgOncol Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer pubmed.ncbi.nlm.nih.gov/4162…
🔵 Post pancreatectomy mortality: the new seminal paper from @ISGPS_news@AnnalsofSurgery
👉 occurring within 90 days from pancreatectomy linked to it through root-cause analysis
3️⃣ categories ✂️ vascular complexity 💦 pancreas specific 🫀 C/P sudden
journals.lww.com/annalsofsur…
Among patients with unexplained acute recurrent #pancreatitis and pancreas divisum, endoscopic retrograde cholangiopancreatography (ERCP) with minor papillotomy does not reduce the risk of another episode of acute pancreatitis or related sequelae.
ja.ma/4qqa4Cm
ALT Infographic detailing a JAMA study on ERCP with minor papillotomy for pancreatitis. It includes data on population (101 women, 47 men), intervention (ERCP vs. Sham ERCP), and findings (rates of acute pancreatitis development).
Have you ever wondered why do large (>3cm) & Mixed Type IPMNs have a higher risk of invasive neoplasia and carcinoma?
In these @JAMASurgery & @acsJACS publications led by @amudhan_kannan for our research group we attempt to decipher the biological behavior of IPMN using NGS
Our new study unveils the association and underlying mechanisms between high spicy diet consumption / capsaicin-induced chronic gut inflammation and idiopathic short stature. @NatureComms
Happy New Year!
nature.com/articles/s41467-0…
Among patients with PDAC undergoing postneoadjuvant pancreatoduodenectomy, revision of pancreatic neck margin did not improve outcomes compared to incomplete resection. journals.lww.com/annalsofsur…
Grateful to @timnewhook19 & @VautheyMD for their guidance throughout this project!
Huge thanks also to my friends & colleagues @mateolendoire@Haddad_Antony for their help!
Treating obstructive jaundice
➕minimizing cholangitis ➕ adequate sFLR 🟰 safe resection of pCCA